Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-002235

Senior VP - Drug Discovery gave up 3,872 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Senior VP - Drug Discovery

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-20 Shares withheld for taxes : show line 1 in the form −3,872 $5.59 $21,644 99,996 D
Loading xslF345X03/form4.xml…